According to ScienceAlert, This equates to around 7.6 million fewer people being counted as obese compared to three years ago, meaning a potential future reduction in obesity-related health conditions, including cancer, heart disease, stroke and mental health issues. Gallup found that this year nearly 10% of men and just over 15% of women are using semaglutide or liraglutide drugs, which are all GLP-1s
Key drugs like semaglutide (Ozempic/Wegovy) and the dual agonist tirzepatide (Mounjaro/Zepbound) are at the forefront of a paradigm shift in treating metabolic disease
Semaglutide is shown to be a superior weight loss agent in comparison to other GLP-1-RA drugs, such as liraglutide
A: No this is a common misconception
Growth hormone influences water balance, tissue repair, glucose metabolism, and dozens of other physiological processes
Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues